One and Done: Why People Are Eager for Johnson & Johnson ’s Vaccine
Johnson& Johnson ’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior.
Source: NYT Health - Category: Consumer Health News Authors: Noah Weiland Tags: Vaccination and Immunization Drugs (Pharmaceuticals) States (US) Income Inequality Meatpacking Plants and Slaughterhouses Food and Drug Administration Federal Emergency Management Agency Johnson & Coronavirus (2019-nCoV) Source Type: news
More News: Coronavirus | COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | Health | Vaccines